REFERENCES
1. Gedfie S, Getawa S, Melku M. Prevalence and associated factors of iron deficiency and iron deficiency anemia among under-5 children: a systematic review and meta-analysis. Glob Pediatr Health 2022;9:2333794X221110860.
2. Giorgetti A, Paganini D, Nyilima S, et al. The effects of 2’-fucosyllactose and lacto-N-neotetraose, galacto-oligosaccharides, and maternal human milk oligosaccharide profile on iron absorption in Kenyan infants. Am J Clin Nutr 2023;117:64-72.
3. Paganini D, Uyoga MA, Kortman GAM, et al. Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants. Gut 2017;66:1956-67.
4. De-Regil LM, Jefferds MED, Peña-Rosas JP. Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age. Cochrane Database Syst Rev 2017;11:CD009666.
5. WHO. WHO guideline: use of multiple micronutrient powders for point-of-use fortification of foods consumed by infants and young children aged 6-23 months and children aged 2-12 years. 2016.
6. WHO. Nutritional anaemias: tools for effective prevention and control. 2017. Available from: https://www.who.int/publications/i/item/9789241513067. [Last accessed on 11 Dec 2024].
7. Puga AM, Samaniego-Vaesken ML, Montero-Bravo A, Ruperto M, Partearroyo T, Varela-Moreiras G. Iron supplementation at the crossroads of nutrition and gut microbiota: the state of the art. Nutrients 2022;14:1926.
8. Tang M, Frank DN, Hendricks AE, et al. Iron in micronutrient powder promotes an unfavorable gut microbiota in Kenyan infants. Nutrients 2017;9:776.
9. Jaeggi T, Kortman GAM, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut 2015;64:731-42.
10. Popovic A, Bourdon C, Wang PW, et al. Micronutrient supplements can promote disruptive protozoan and fungal communities in the developing infant gut. Nat Commun 2021;12:6729.
11. Mikulic N, Uyoga MA, Stoffel NU, et al. Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants. Am J Clin Nutr 2024;119:456-69.
12. Rai D, Adelman AS, Zhuang W, Rai GP, Boettcher J, Lönnerdal B. Longitudinal changes in lactoferrin concentrations in human milk: a global systematic review. Crit Rev Food Sci Nutr 2014;54:1539-47.
13. Donker AE, van der Staaij H, Swinkels DW. The critical roles of iron during the journey from fetus to adolescent: developmental aspects of iron homeostasis. Blood Rev 2021;50:100866.
14. Oda H, Wakabayashi H, Yamauchi K, Abe F. Lactoferrin and bifidobacteria. Biometals 2014;27:915-22.
15. Gruden Š, Ulrih NP. Diverse mechanisms of antimicrobial activities of lactoferrins, lactoferricins, and other lactoferrin-derived peptides. Int J Mol Sci 2021;22:11264.
16. Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, García-Montoya IA, Salazar-Martínez J, Rascón-Cruz Q. Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin 2014;35:557-66.
17. Chen K, Chai L, Li H, et al. Effect of bovine lactoferrin from iron-fortified formulas on diarrhea and respiratory tract infections of weaned infants in a randomized controlled trial. Nutrition 2016;32:222-7.
18. Motoki N, Mizuki M, Tsukahara T, et al. Effects of lactoferrin-fortified formula on acute gastrointestinal symptoms in children aged 12-32 months: a randomized, double-blind, placebo-controlled trial. Front Pediatr 2020;8:233.
19. Mikulic N, Uyoga MA, Mwasi E, et al. Iron absorption is greater from apo-lactoferrin and is similar between holo-lactoferrin and ferrous sulfate: stable iron isotope studies in Kenyan infants. J Nutr 2020;150:3200-7.
20. ClinicalTrials.gov. Prebiotic GOS and lactoferrin with iron supplements. Available from: https://clinicaltrials.gov/study/NCT03866837. [Last accessed on 11 Dec 2024].
21. Vogt JA, Wolever TMS. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003;133:3145-8.
22. Isenring J, Bircher L, Geirnaert A, Lacroix C. In vitro human gut microbiota fermentation models: opportunities, challenges, and pitfalls. Microbiome Res Rep 2023;2:2.
23. Zihler Berner A, Fuentes S, Dostal A, et al. Novel polyfermentor intestinal model (PolyFermS) for controlled ecological studies: validation and effect of pH. PLoS One 2013;8:e77772.
24. Doo EH, Chassard C, Schwab C, Lacroix C. Effect of dietary nucleosides and yeast extracts on composition and metabolic activity of infant gut microbiota in PolyFermS colonic fermentation models. FEMS Microbiol Ecol 2017;93:fix088.
25. Dostal A, Gagnon M, Chassard C, Zimmermann MB, O’Mahony L, Lacroix C. Salmonella adhesion, invasion and cellular immune responses are differentially affected by iron concentrations in a combined in vitro gut fermentation-cell model. PLoS One 2014;9:e93549.
26. Rachmühl C, Lacroix C, Cabrera PM, Geirnaert A. Long-term continuous cultivation of Kenyan infant fecal microbiota using the host adapted PolyFermS model. Sci Rep 2023;13:20563.
27. Cabrera P, Rachmühl C, Derrien M, Bourdet-Sicard R, Lacroix C, Geirnaert A. Comparative prebiotic potential of galacto- and fructo-oligosaccharides, native inulin, and acacia gum in Kenyan infant gut microbiota during iron supplementation. ISME Commun 2024;4:ycae033.
28. Poeker SA, Geirnaert A, Berchtold L, et al. Understanding the prebiotic potential of different dietary fibers using an in vitro continuous adult fermentation model (PolyFermS). Sci Rep 2018;8:4318.
29. Hernandez RJ, Gutowski D, Guire KE. Capacity of the colon in children. AJR Am J Roentgenol 1979;133:683-4.
30. Heinemann M, Strauchs C, Lütgehetmann M, et al. Polymicrobial enteric infections in African infants with diarrhoea-results from a longitudinal prospective case-control study. Clin Microbiol Infect 2021;27:1792-8.
31. Mikulic N, Uyoga MA, Paganini D, et al. Consumption of a single dose of prebiotic galacto-oligosaccharides does not enhance iron absorption from micronutrient powders in Kenyan infants: a stable iron isotope study. J Nutr 2021;151:1205-12.
32. Tondeur MC, Schauer CS, Christofides AL, et al. Determination of iron absorption from intrinsically labeled microencapsulated ferrous fumarate (sprinkles) in infants with different iron and hematologic status by using a dual-stable-isotope method. Am J Clin Nutr 2004;80:1436-44.
33. Walczyk T, Davidsson L, Zavaleta N, Hurrell RF. Stable isotope labels as a tool to determine the iron absorption by Peruvian school children from a breakfast meal. Fresenius J Anal Chem 1997;359:445-9.
34. Stoddard SF, Smith BJ, Hein R, Roller BR, Schmidt TM. rrnDB: improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development. Nucleic Acids Res 2015;43:D593-8.
35. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 2016;13:581-3.
37. Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 2013;41:D590-6.
38. Vidal RM, Muhsen K, Tennant SM, et al. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis 2019;13:e0007037.
39. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013;8:e61217.
40. Oksanen AJ, Blanchet FG, Kindt R, et al. vegan: an R package for community ecologists. Available from: https://github.com/vegandevs/vegan. [Last accessed on 17 Dec 2024]
42. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15:550.
43. Dostal A, Fehlbaum S, Chassard C, Zimmermann MB, Lacroix C. Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. FEMS Microbiol Ecol 2013;83:161-75.
44. Celis AI, Relman DA, Huang KC. The impact of iron and heme availability on the healthy human gut microbiome in vivo and in vitro. Cell Chem Biol 2023;30:110-26.e3.
45. Fanaro S, Marten B, Bagna R, et al. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 2009;48:82-8.
46. Scholtens PA, Alles MS, Bindels JG, van der Linde EG, Tolboom JJ, Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr 2006;42:553-9.
47. Souza DDS, Tahan S, Weber TK, Araujo-Filho HB, de Morais MB. Randomized, double-blind, placebo-controlled parallel clinical trial assessing the effect of fructooligosaccharides in infants with constipation. Nutrients 2018;10:1602.
48. Logtenberg MJ, Akkerman R, Hobé RG, et al. Structure-specific fermentation of galacto-oligosaccharides, isomalto-oligosaccharides and isomalto/malto-polysaccharides by infant fecal microbiota and impact on dendritic cell cytokine responses. Mol Nutr Food Res 2021;65:e2001077.
49. Le Blay G, Chassard C, Baltzer S, Lacroix C. Set up of a new in vitro model to study dietary fructans fermentation in formula-fed babies. Br J Nutr 2010;103:403-11.
50. Yao D, Wu M, Dong Y, et al. In vitro fermentation of fructooligosaccharide and galactooligosaccharide and their effects on gut microbiota and SCFAs in infants. J Funct Foods 2022;99:105329.
51. Martinez FA, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP. Bacteriocin production by Bifidobacterium spp. a review. Biotechnol Adv 2013;31:482-8.
52. Vazquez-Gutierrez P, de Wouters T, Werder J, Chassard C, Lacroix C. High iron-sequestrating bifidobacteria inhibit enteropathogen growth and adhesion to intestinal epithelial cells in vitro. Front Microbiol 2016;7:1480.
53. McDonald JAK, Mullish BH, Pechlivanis A, et al. Inhibiting growth of clostridioides difficile by restoring valerate, produced by the intestinal microbiota. Gastroenterology 2018;155:1495-507.e15.
54. Hryckowian AJ, Van Treuren W, Smits SA, et al. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model. Nat Microbiol 2018;3:662-9.
55. Kondepudi KK, Ambalam P, Nilsson I, Wadström T, Ljungh A. Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile. Anaerobe 2012;18:489-97.
56. Embleton N, Berrington J, Cummings S, Dorling J, Ewer A, Frau A, et al. Lactoferrin impact on gut microbiota in preterm infants with late-onset sepsis or necrotising enterocolitis: the MAGPIE mechanisms of action study. Effic Mech Eval 2021;8:1-88.
57. Sherman MP, Sherman J, Arcinue R, Niklas V. Randomized control trial of human recombinant lactoferrin: a substudy reveals effects on the fecal microbiome of very low birth weight infants. J Pediatr 2016;173:S37-42.
58. Chichlowski M, Bokulich N, Harris CL, et al. Effect of bovine milk fat globule membrane and lactoferrin in infant formula on gut microbiome and metabolome at 4 months of age. Curr Dev Nutr 2021;5:nzab027.
59. Young G, Berrington JE, Cummings S, et al. Mechanisms affecting the gut of preterm infants in enteral feeding trials: a nested cohort within a randomised controlled trial of lactoferrin. Arch Dis Child Fetal Neonatal Ed 2023;108:272-9.
60. Haiwen Z, Rui H, Bingxi Z, et al. Oral administration of bovine lactoferrin-derived lactoferricin (Lfcin) b could attenuate enterohemorrhagic Escherichia coli O157:H7 induced intestinal disease through improving intestinal barrier function and microbiota. J Agric Food Chem 2019;67:3932-45.
61. Teraguchi S, Shin K, Ozawa K, et al. Bacteriostatic effect of orally administered bovine lactoferrin on proliferation of Clostridium species in the gut of mice fed bovine milk. Appl Environ Microbiol 1995;61:501-6.
62. Rastogi N, Nagpal N, Alam H, et al. Preparation and antimicrobial action of three tryptic digested functional molecules of bovine lactoferrin. PLoS One 2014;9:e90011.
63. Lönnerdal B, Du X, Jiang R. Biological activities of commercial bovine lactoferrin sources. Biochem Cell Biol 2021;99:35-46.
64. Chilton CH, Crowther GS, Śpiewak K, et al. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection. J Antimicrob Chemother 2016;71:975-85.
65. Kortman GAM, Boleij A, Swinkels DW, Tjalsma H. Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One 2012;7:e29968.
66. Bhakat D, Mondal I, Mukhopadhyay AK, Chatterjee NS. Iron influences the expression of colonization factor CS6 of enterotoxigenic Escherichia coli. Microbiology 2021;167:001089.
67. Hinrichsen F, Hamm J, Westermann M, et al. Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis. Cell Metab 2021;33:2355-66.e8.
